| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
289,870,000 |
| Market
Cap: |
58.23(B) |
| Last
Volume: |
2,473,932 |
Avg
Vol: |
1,571,706 |
| 52
Week Range: |
$165.15 - $249.08 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 11.4 |
| Insider 3/6 Months : 12 |
|
| Guru Rank Number : 77 |
| Guru Rank Value : 11.5 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s business segments are: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers; and BD Interventional, which provides vascular, urology, oncology and surgical products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
5,250 |
6,750 |
6,750 |
| Total Buy Value |
$0 |
$1,005,743 |
$1,356,173 |
$1,356,173 |
| Total People Bought |
0 |
1 |
2 |
2 |
| Total Buy Transactions |
0 |
1 |
2 |
2 |
| Total Shares Sold |
407 |
3,429 |
13,683 |
30,201 |
| Total Sell Value |
$73,923 |
$636,746 |
$2,901,406 |
$6,683,405 |
| Total People Sold |
2 |
4 |
7 |
9 |
| Total Sell Transactions |
4 |
8 |
18 |
27 |
| End Date |
2025-09-14 |
2025-06-13 |
2024-12-13 |
2023-12-14 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Roque Vitor |
Interim CFOOfficer |
• – – |
2025-12-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,477 |
|
4% |
|
| Huffines Robert Luther |
Director |
– • – |
2025-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
180 |
180 |
|
- |
|
| Wright Jacqueline |
Director |
– • – |
2025-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
180 |
180 |
|
- |
|
| Feld Michael |
EVP, CRO & Pres. Life Sciences |
• – – |
2025-12-01 |
4 |
S |
$193.36 |
$14,502 |
D/D |
(75) |
16,580 |
|
-5% |
|
| Byrd Richard |
EVP & President Interventional |
• – – |
2025-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,719) |
13,849 |
|
- |
|
| Byrd Richard |
EVP & President Interventional |
• – – |
2025-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
8,832 |
15,568 |
|
- |
|
| Goette Roland |
EVP and President, EMEA |
• – – |
2025-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(138) |
17,222 |
|
- |
|
| Goette Roland |
EVP and President, EMEA |
• – – |
2025-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
3,143 |
17,360 |
|
- |
|
| Spikner Pamela L. |
SVPController & Chief Acct Off |
• – – |
2025-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,234 |
1,916 |
|
- |
|
| Polen Thomas E Jr |
Chairman, CEO and President |
• – – |
2025-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(17,421) |
105,471 |
|
- |
|
| Polen Thomas E Jr |
Chairman, CEO and President |
• – – |
2025-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
22,521 |
122,892 |
|
- |
|
| Feld Michael |
EVP, CRO & Pres. Life Sciences |
• – – |
2025-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(419) |
16,655 |
|
- |
|
| Feld Michael |
EVP, CRO & Pres. Life Sciences |
• – – |
2025-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
8,829 |
17,074 |
|
- |
|
| Muhsin Bilal |
EVP & President Connected Care |
• – – |
2025-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
9,530 |
21,751 |
|
- |
|
| Neal Shana Carol |
EVP and Chief People Officer |
• – – |
2025-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,454) |
21,326 |
|
- |
|
| Neal Shana Carol |
EVP and Chief People Officer |
• – – |
2025-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,252 |
23,780 |
|
- |
|
| Mocherla Pavan Kumar |
EVP & President, Greater Asia |
• – – |
2025-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
2,916 |
5,763 |
|
- |
|
| Shan David |
EVP and Chief ISC Officer |
• – – |
2025-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(134) |
8,970 |
|
- |
|
| Shan David |
EVP and Chief ISC Officer |
• – – |
2025-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
4,529 |
9,104 |
|
- |
|
| Delorefice Christopher |
EVP & Chief Financial Officer |
• – – |
2025-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,245) |
22,982 |
|
- |
|
| Delorefice Christopher |
EVP & Chief Financial Officer |
• – – |
2025-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
6,006 |
27,227 |
|
- |
|
| Garrison Michael David |
EVP & Pres Med.Essntl&BioPharm |
• – – |
2025-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,769) |
13,734 |
|
- |
|
| Garrison Michael David |
EVP & Pres Med.Essntl&BioPharm |
• – – |
2025-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,616 |
15,503 |
|
- |
|
| Scott Bertram L |
Director |
– • – |
2025-11-07 |
4 |
S |
$176.58 |
$38,318 |
D/D |
(217) |
35,816 |
|
-13% |
|
| Feld Michael |
EVP & President, Life Sciences |
• – – |
2025-10-27 |
4 |
S |
$186.01 |
$10,603 |
D/D |
(57) |
8,245 |
|
-7% |
|
796 Records found
|
|
Page 1 of 32 |
|
|
0.46 (0.23%) 
